Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection

被引:0
作者
Bruno, Ann M. [1 ,2 ,5 ]
Allshouse, Amanda A. [1 ]
Benson, Ashley E. [3 ]
Yost, Christian Con [1 ,4 ]
Metz, Torri D. [1 ,2 ]
Varner, Michael W. [1 ]
Silver, Robert M. [1 ]
Branch, D. Ware [1 ,2 ]
机构
[1] Univ Utah Hlth, Dept Obstet & Gynecol, Salt Lake City, UT USA
[2] Intermt Hlth, Dept Obstet & Gynecol, Salt Lake City, UT USA
[3] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR USA
[4] Univ Utah, Mol Med Program, Salt Lake City, UT USA
[5] Univ Utah Hlth, Dept Obstetr & Gynecol, 30 N 1900,Suite 2B200, Salt Lake City, UT 84132 USA
基金
美国国家卫生研究院;
关键词
thromboembolism; thrombotic biomarkers; SARS-CoV-2; infection; lupus anticoagulant; D-dimer; CORONAVIRUS DISEASE 2019; D-DIMER; ANTIPHOSPHOLIPID ANTIBODIES; ILL PATIENTS; COVID-19; GUIDELINES; GUIDANCE; DEATH;
D O I
10.1055/a-2211-5052
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Coronavirus disease 2019 (COVID-19) is associated with coagulation abnormalities and increased risk for venous and arterial thrombi. This study aimed to evaluate D-dimer levels and lupus anticoagulant (LAC) positivity in pregnant individuals with and without Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Study design:<bold> </bold>This was a prospective cohort study of pregnant individuals delivering at a single academic institution from April 2020 to March 2022. Individuals with a positive SARS-CoV-2 result during pregnancy were compared with a convenience sample of those without a positive SARS-CoV-2 result. For individuals with SARS-CoV-2 infection, severity was assessed based on the National Institutes of Health classification system. The primary outcome was D-dimer level measured during delivery admission. The secondary outcomes were LAC positivity and thromboembolic events. Outcomes were compared between individuals with and without a positive SARS-CoV-2 result, and further by disease severity.Results:<bold> </bold>Of 98 participants, 77 (78.6%) were SARS-CoV-2 positive during pregnancy. Among individuals with SARS-CoV-2 infection, severity was asymptomatic in 20 (26.0%), mild in 13 (16.9%), moderate in 4 (5.2%), severe in 38 (49.4%), and critical in 2 (2.6%). The D-dimer concentration at delivery did not significantly differ between those with a SARS-CoV-2 positive result compared with those without (mean 2.03 mu g/mL [95% confidence interval {CI} 1.72-2.40] vs. 2.37 mu g/mL [95% CI 1.65-3.40]; p = 0.43). Three individuals (4%) with SARS-CoV-2 infection and none (0%) without infection were LAC positive (p = 0.59). There were no clinically apparent thromboses in either group. D-dimer concentrations and LAC positive results did not differ by COVID-19 severity.Conclusion: Thrombotic markers did not differ in pregnant individuals by SARS-CoV-2 infection; however, high rates of LAC positivity were detected.
引用
收藏
页码:e3202 / e3209
页数:8
相关论文
共 50 条
  • [1] First COVID-19 maternal mortality in the UK associated with thrombotic complications
    Ahmed, Irshad
    Azhar, Ahamed
    Eltaweel, Nashwa
    Tan, Bee K.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : E37 - +
  • [2] *AM COLL OF OBST A, 2018, OBSTET GYNECOL, V132, pE1, DOI DOI 10.1097/AOG.0000000000002706
  • [3] Coagulation changes and thromboembolic risk in COVID-19 obstetric patients
    Benhamou, Dan
    Keita, Hawa
    Ducloy-Bouthors, Anne Sophie
    Bonnet, Marie Pierre
    Bonnin, Martine
    Bouthors, Anne Sophie
    Bouvet, Lionel
    Castel, Adeline
    Chassard, Dominique
    Dewandre, Pierre Yves
    Fisher, Catherine
    Julliac, Benjamin
    Mercier, Frederic J.
    Morau, Estelle
    Rackelboom, Thibault
    Vial, Florence
    Wernet, Anne
    [J]. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2020, 39 (03) : 351 - 353
  • [4] COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
    Bikdeli, Behnood
    Madhavan, Mahesh V.
    Jimenez, David
    Chuich, Taylor
    Dreyfus, Isaac
    Driggin, Elissa
    Der Nigoghossian, Caroline
    Ageno, Walter
    Madjid, Mohammad
    Guo, Yutao
    Tang, Liang V.
    Hu, Yu
    Giri, Jay
    Cushman, Mary
    Quere, Isabelle
    Dimakakos, Evangelos P.
    Gibson, C. Michael
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Fareed, Jawed
    Caprini, Joseph A.
    Tafur, Alfonso J.
    Burton, John R.
    Francese, Dominic P.
    Wang, Elizabeth Y.
    Falanga, Anna
    McLintock, Claire
    Hunt, Beverley J.
    Spyropoulos, Alex C.
    Barnes, Geoffrey D.
    Eikelboom, John W.
    Weinberg, Ido
    Schulman, Sam
    Carrier, Marc
    Piazza, Gregory
    Beckman, Joshua A.
    Steg, Gabriel
    Stone, Gregg W.
    Rosenkranz, Stephan
    Goldhaber, Samuel Z.
    Parikh, Sahil A.
    Monreal, Manuel
    Krumholz, Harlan M.
    Konstantinides, Stavros V.
    Weitz, Jeffrey I.
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) : 2950 - 2973
  • [5] Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
    Bowles, Louise
    Platton, Sean
    Yartey, Nada
    Dave, Minal
    Lee, Kurtis
    Hart, Daniel P.
    MacDonald, Vickie
    Green, Laura
    Sivapalaratnam, Suthesh
    Pasi, K. John
    MacCallum, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (03) : 288 - 290
  • [6] Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
    Caso, Francesco
    Costa, Luisa
    Ruscitti, Piero
    Navarini, Luca
    Del Puente, Antonio
    Giacomelli, Roberto
    Scarpa, Raffaele
    [J]. AUTOIMMUNITY REVIEWS, 2020, 19 (05)
  • [7] Antiphospholipid Syndrome
    Branch, Ware
    Holmgren, Calla
    Goldberg, James D.
    [J]. OBSTETRICS AND GYNECOLOGY, 2012, 120 (06) : 1514 - 1521
  • [8] COVID-19 and its implications for thrombosis and anticoagulation
    Connors, Jean M.
    Levy, Jerrold H.
    [J]. BLOOD, 2020, 135 (23) : 2033 - 2040
  • [9] Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
    Cui, Songping
    Chen, Shuo
    Li, Xiunan
    Liu, Shi
    Wang, Feng
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1421 - 1424
  • [10] Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation
    Devreese, Katrien M. J.
    de Groot, Philip G.
    de Laat, Bas
    Erkan, Doruk
    Favaloro, Emmanuel J.
    Mackie, Ian
    Martinuzzo, Marta
    Ortel, Thomas L.
    Pengo, Vittorio
    Rand, Jacob H.
    Tripodi, Armando
    Wahl, Denis
    Cohen, Hannah
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (11) : 2828 - 2839